Transport of quercetin di-sodium salt in the human intestinal epithelial Caco-2 cell monolayer 139

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 32, Issue 3, 2007, Pages 139-147

  Milane, H A ^a   Al Ahmad, A ^a   Naitchabane, M ^a   Vandamme, T F ^a   Jung, L ^b   Ubeaud, Geneviève ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Caco 2 cell line; Intestinal transport; Quercetin; Quercetin di sodium salt

Indexed keywords

DRUG CARRIER; PHLORIZIN; QUERCETIN; QUERCETIN DERIVATIVE; SODIUM GLUCOSE COTRANSPORTER 1;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG INHIBITION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; MONOLAYER CULTURE; PH MEASUREMENT;

EID: 36549022609     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190476     Document Type: Article

References (18)

1. Hertog M.G.L., Hollman P.C.H., Katan M.B. (1992): Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J. Agric. Food Chem., 40, 2379-2383.
2. Herrmann K. (1976): Flavonoids and flavonones in food plants: a review. J. Food Technol. 11, 433-448.
3. Bokkenheuser V. D., Shackleton C. H. L., Winter J., (1987): Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem. J., 248, 953-956.
4. Terao J. (1999): Dietary flavonoids as plasma antioxidants on lipid peroxidation: Significance of metabolic conversion. In: Packer, L., Hiramatsu, M., Yoshikawa, T. (Eds), Antioxidant food supplements in human health. New York: Academic Press, 255-268.
5. Murota K., Terao J. (2003): Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys., 417, 12-17.
6. Walle T. (2004): Absorption and metabolism of flavonoids. Free Radic. Biol. Med., 36, 829-837.
7. Scalbert A., Morand C., Manach C., Remesy C. (2002): Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother., 56, 276-282.
8. Rice-Evans C.A., Miller N.J., Paganga G. (1996): Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 20, 933-956.
9. Milane A.H., Ubeaud G., Vandamme T.F., Jung L. (2004): Isolation of quercetins salts and studies of their physicochemical properties and antioxidant relationships. Bioorg. Med. Chem., 12, 3627-3635.
10. Artursson P. (1990): Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci., 79, 476-482.
11. Meunier V., Bourrié M., Berger Y., Fabre G. (1995): The human intestinal epithelial cell line Caco-2. Pharmacological and pharmacokinetic applications. Cell Biol. Toxicol., 11, 187-194.
12. Lo Y.L. (2000): Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol., 60, 1381-1390.
13. Bradford M.M. (1976): A rapid and sensitive method for the quantification of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
14. Artursson P., Karlsson J. (1991): Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, 880-885.
15. Cermak R., Landgraf S., Wolffram S. (2004): Quercetin glucosides inhibit glucose uptake into brush-border membrane vesicles of porcine jejunum. Br. J. Nutr., 91, 849-855.
16. Walgren R.A., Walle U.K., Walle T. (1998): Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol., 55, 1721-1727.
17. Day A.J., Gee J.M., DuPont M.S., Johnson I.T., Williamson G. (2003): Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem. Pharmacol., 65 (7), 1199-1206.
18. Ader, P., Blöck, M., Pietzsch, S., Wolffram, S. (2001): Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett., 162, 175-180.